A roundtable titled “Exorehabilitation – key directions and methods” took place online on 27 April. Representatives of the Skolkovo resident company ExoAtlet discussed opportunities with specialists on the adoption of exoskeletons into medical...
Biomarker-RU, a resident of the Skolkovo Foundation biomedicine technologies cluster, has attracted $3.5 million of venture capital to further develop its early diagnostics test for breast cancer – ARNA Breast. ARNA-Breast utilizes a method for detecting...